Glucose Control Targets in Type 2 Diabetes Mellitus
For adults with type 2 diabetes, maintain fasting blood sugar (FBS) between 80-130 mg/dL and post-prandial blood sugar (PPBS) below 180 mg/dL, measured 1-2 hours after starting a meal. 1, 2
Fasting Blood Sugar (FBS) Targets
The recommended preprandial capillary plasma glucose target is 80-130 mg/dL for most nonpregnant adults with type 2 diabetes. 3, 1, 4
- The lower limit was specifically raised from 70 mg/dL to 80 mg/dL to provide a safety margin and limit overtreatment in patients using glucose-lowering medications, particularly insulin 1, 4
- Blood glucose below 70 mg/dL constitutes clinically important hypoglycemia requiring immediate treatment with 15-20g of fast-acting carbohydrate 1, 4
- Blood glucose below 54 mg/dL represents Level 2 hypoglycemia where neuroglycopenic symptoms begin, indicating serious, clinically important hypoglycemia 1, 4
Post-Prandial Blood Sugar (PPBS) Targets
Peak postprandial capillary plasma glucose should remain below 180 mg/dL, measured 1-2 hours after beginning the meal. 3, 1, 2
- This target has remained consistent across American Diabetes Association guidelines from 2004 through 2024, indicating strong consensus on its importance 3, 2
- Postprandial measurements must be standardized at 1-2 hours after meal start to capture peak glucose levels accurately 1, 2
- When A1C goals are not met despite achieving fasting glucose targets, postprandial glucose monitoring becomes critical to identify excessive postprandial excursions requiring specific intervention 1, 2, 5
Clinical Context and Rationale
Postprandial glucose control accounts for approximately 80% of HbA1c when HbA1c is below 6.2%, but only about 40% when HbA1c exceeds 9.0%. 6
- Research demonstrates that 70% of patients with HbA1c below 7% still have postprandial glucose values exceeding 160 mg/dL after meals 7
- Among type 2 diabetes patients treated with basal insulin who achieve adequate fasting glucose control (below 130 mg/dL), approximately 23.5% still fail to achieve HbA1c targets below 7% due to uncontrolled postprandial excursions 5
- Control of fasting hyperglycemia alone is necessary but usually insufficient for achieving HbA1c goals below 7%; control of postprandial hyperglycemia is essential 6
Monitoring Frequency Based on Treatment Regimen
Patients on intensive insulin therapy should check glucose before meals and snacks, at bedtime, occasionally postprandially, and before/during/after exercise, typically requiring 6-10 checks daily. 1
- For patients on single daily basal insulin injections, daily fasting blood glucose measurements are suggested as the fasting value best reflects the appropriateness of the basal insulin dose 3
- More frequent monitoring is reasonable when glycemia is unstable, patients are prone to hypoglycemia, or treatment changes are made 1
Target Modification Based on Patient Characteristics
More stringent HbA1c targets (6.0-6.5%) may be considered in selected patients with short disease duration, long life expectancy, and no significant cardiovascular disease if achievable without significant hypoglycemia. 3
Less stringent HbA1c goals (7.5-8.0% or slightly higher) are appropriate for patients with:
- History of severe hypoglycemia 3, 4
- Limited life expectancy 3, 4
- Advanced complications 3
- Extensive comorbid conditions 3
- Difficulty attaining targets despite intensive self-management education and multiple glucose-lowering agents including insulin 3
Critical Pitfalls to Avoid
Do not rely solely on fasting glucose or HbA1c to assess glycemic control, as postprandial excursions can be missed entirely. 1, 2
- Ignoring postprandial glucose when A1C goals are not met despite good fasting values is a common error that leaves excessive postprandial excursions unaddressed 1, 2
- Measuring postprandial glucose at inconsistent times should be avoided; standardize at 1-2 hours after meal start 1, 2
- Setting fasting targets too low (below 80 mg/dL) increases hypoglycemia risk without clear benefit 1, 4
- The coefficient of correlation between fasting plasma glucose and HbA1c is only 0.73, meaning fasting glucose alone poorly predicts overall glycemic control 7